Editas Medicine (EDIT) Change in Accured Expenses (2015 - 2025)

Editas Medicine (EDIT) has reported Change in Accured Expenses for 11 consecutive years, with -$543000.0 the latest figure, recorded in Q3 2025.

• In Q3 2025, Change in Accured Expenses fell 153.5% year-over-year to -$543000.0; the TTM figure through Sep 2025 stood at $18.9 million (up 1418.94% YoY), while the FY2024 annual figure was $11.6 million, up 182.52% from the prior year.
• Change in Accured Expenses eased to -$543000.0 in Q3 2025 per EDIT's latest filing, from $578000.0 in the prior quarter.
• Across five years, Change in Accured Expenses topped out at $17.1 million in Q4 2024 and bottomed at -$9.6 million in Q1 2021.
• Historically, Change in Accured Expenses has averaged $1.3 million across 5 years, with a median of $1.0 million in 2024.
• Annual changes were most pronounced in 2021 — Change in Accured Expenses surged 1905.82% — and 2024, when it sank 288.79%.
• Editas Medicine's Change in Accured Expenses stood at $5.3 million in 2021, then soared by 108.42% to $11.0 million in 2022, then slumped by 62.77% to $4.1 million in 2023, then surged by 319.01% to $17.1 million in 2024, then plunged by 103.17% to -$543000.0 in 2025.
• Business Quant data shows EDIT's Change in Accured Expenses at -$543000.0 in Q3 2025, $578000.0 in Q2 2025, and $1.7 million in Q1 2025.